104 related articles for article (PubMed ID: 12883726)
1. Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate.
Ogawa Y; Murata Y; Saibara T; Nishioka A; Kariya S; Yoshida S
Oncol Rep; 2003; 10(5):1473-8. PubMed ID: 12883726
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen induced-non-alcoholic steatohepatitis (NASH): has the time come for the oncologist to be diabetologist.
Ahmed MH; Osman KA
Breast Cancer Res Treat; 2006 May; 97(2):223-4. PubMed ID: 16322887
[No Abstract] [Full Text] [Related]
3. The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer.
Saphner T; Triest-Robertson S; Li H; Holzman P
Cancer; 2009 Jul; 115(14):3189-95. PubMed ID: 19484789
[TBL] [Abstract][Full Text] [Related]
4. Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.
Hamada N; Ogawa Y; Saibara T; Murata Y; Kariya S; Nishioka A; Terashima M; Inomata T; Yoshida S
Int J Oncol; 2000 Dec; 17(6):1119-23. PubMed ID: 11078796
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen-induced non-alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis.
Murata Y; Ogawa Y; Saibara T; Nishioka A; Takeuchi N; Kariya S; Onishi S; Yoshida S
Oncol Rep; 2003; 10(1):97-100. PubMed ID: 12469151
[TBL] [Abstract][Full Text] [Related]
6. Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes.
Morita Y; Ueno T; Sasaki N; Tateishi Y; Nagata E; Kage M; Sata M
Hepatogastroenterology; 2005; 52(65):1338-43. PubMed ID: 16201069
[TBL] [Abstract][Full Text] [Related]
7. Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients.
Murata Y; Ogawa Y; Saibara T; Nishioka A; Fujiwara Y; Fukumoto M; Inomata T; Enzan H; Onishi S; Yoshida S
Oncol Rep; 2000; 7(6):1299-304. PubMed ID: 11032933
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
9. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.
Saibara T; Onishi S; Ogawa Y; Yoshida S; Enzan H
Lancet; 1999 May; 353(9166):1802. PubMed ID: 10348023
[No Abstract] [Full Text] [Related]
10. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
Harrison SA; Torgerson S; Hayashi PH
Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
[TBL] [Abstract][Full Text] [Related]
11. [Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)].
Podymova SD
Ter Arkh; 2006; 78(4):32-8. PubMed ID: 16821419
[TBL] [Abstract][Full Text] [Related]
12. Dietary habits and nutrient intake in non-alcoholic steatohepatitis.
Toshimitsu K; Matsuura B; Ohkubo I; Niiya T; Furukawa S; Hiasa Y; Kawamura M; Ebihara K; Onji M
Nutrition; 2007 Jan; 23(1):46-52. PubMed ID: 17140767
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic steatohepatitis in type 2 diabetes mellitus.
Gupte P; Amarapurkar D; Agal S; Baijal R; Kulshrestha P; Pramanik S; Patel N; Madan A; Amarapurkar A; Hafeezunnisa
J Gastroenterol Hepatol; 2004 Aug; 19(8):854-8. PubMed ID: 15242486
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
[TBL] [Abstract][Full Text] [Related]
15. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
Helling TS; Helzberg JH; Nachnani JS; Gurram K
Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
[TBL] [Abstract][Full Text] [Related]
16. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
17. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
18. Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy.
Nishino M; Hayakawa K; Nakamura Y; Morimoto T; Mukaihara S
AJR Am J Roentgenol; 2003 Jan; 180(1):129-34. PubMed ID: 12490491
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
[TBL] [Abstract][Full Text] [Related]
20. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
